Global Stem Cell Banking Market 2021-2025

The publisher has been monitoring the stem cell banking market and it is poised to grow by $4.61 bn during 2021-2025, progressing at a CAGR of 8.08% during the forecast period. The report on the stem cell banking market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increased federal investment in stem cell therapy and the rising prevalence of several chronic disorders.

The stem cell banking market analysis includes the type segment and geographic landscape.

The stem cell banking market is segmented as below:

By Type

Adult stem cells
Umbilical cord blood stem cells
Embryonic stem cells

By Geographical Landscape

North America
Europe
Asia
ROW

This study identifies the growing demand for personalized medicines as one of the prime reasons driving the stem cell banking market growth during the next few years.

The report on stem cell banking market covers the following areas:

Stem cell banking market sizing
Stem cell banking market forecast
Stem cell banking market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading stem cell banking market vendors that include Cordlife Group Ltd., CordVida, Covis Pharma BV, Cryo Stemcell, Cryo-Cell International Inc., Cryoviva Biotech Pvt. Ltd., FUJIFILM Holdings Corp., Global Cord Blood Corp., PerkinElmer Inc., and Plus Therapeutics Inc. Also, the stem cell banking market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Executive Summary

Market Overview

Market Landscape

Market ecosystem
Value chain analysis

Market Sizing

Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis

Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Type

Market segments
Comparison by Type
Adult stem cells - Market size and forecast 2020-2025
Umbilical cord blood stem cells - Market size and forecast 2020-2025
Embryonic stem cells - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape

Geographic Landscape

Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape

Overview
Vendor landscape
Landscape disruption

Vendor Analysis

Vendors covered
Market positioning of vendors
Cordlife Group Ltd.
CordVida
Covis Pharma BV
Cryo Stemcell
Cryo-Cell International Inc.
Cryoviva Biotech Pvt. Ltd.
FUJIFILM Holdings Corp.
Global Cord Blood Corp.
PerkinElmer Inc.
Plus Therapeutics Inc.

Appendix

Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

List of Exhibits

Key Finding 1
Key Finding 2
Key Finding 3
Key Finding 5
Key Finding 6
Key Finding 7
Key Finding 8
Parent market
Market characteristics
Offerings of vendors included in the market definition
Market segments
Global - Market size and forecast 2020 - 2025 ($ million)
Global market: Year-over-year growth 2020 - 2025 (%)
Five forces analysis 2020 & 2025
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition - Five forces 2020
Type - Market share 2020-2025 (%)
Comparison by Type
Adult stem cells - Market size and forecast 2020-2025 ($ million)
Adult stem cells - Year-over-year growth 2020-2025 (%)
Umbilical cord blood stem cells - Market size and forecast 2020-2025 ($ million)
Umbilical cord blood stem cells - Year-over-year growth 2020-2025 (%)
Embryonic stem cells - Market size and forecast 2020-2025 ($ million)
Embryonic stem cells - Year-over-year growth 2020-2025 (%)
Market opportunity by Type
Customer landscape
Market share By Geographical Landscape 2020-2025 (%)
Geographic comparison
North America - Market size and forecast 2020-2025 ($ million)
North America - Year-over-year growth 2020-2025 (%)
Europe - Market size and forecast 2020-2025 ($ million)
Europe - Year-over-year growth 2020-2025 (%)
Asia - Market size and forecast 2020-2025 ($ million)
Asia - Year-over-year growth 2020-2025 (%)
ROW - Market size and forecast 2020-2025 ($ million)
ROW - Year-over-year growth 2020-2025 (%)
Key leading countries
Market opportunity By Geographical Landscape ($ million)
Impact of drivers and challenges
Vendor landscape
Landscape disruption
Industry risks
Vendors covered
Market positioning of vendors
Cordlife Group Ltd. - Overview
Cordlife Group Ltd. - Business segments
Cordlife Group Ltd. - Key offerings
Cordlife Group Ltd. - Key customers
Cordlife Group Ltd. - Segment focus
CordVida - Overview
CordVida - Product and service
CordVida - Key offerings
CordVida - Key customers
CordVida - Segment focus
Covis Pharma BV - Overview
Covis Pharma BV - Product and service
Covis Pharma BV - Key offerings
Covis Pharma BV - Key customers
Covis Pharma BV - Segment focus
Cryo Stemcell - Overview
Cryo Stemcell - Product and service
Cryo Stemcell - Key offerings
Cryo Stemcell - Key customers
Cryo Stemcell - Segment focus
Cryo-Cell International Inc. - Overview
Cryo-Cell International Inc. - Business segments
Cryo-Cell International Inc. - Key offerings
Cryo-Cell International Inc. - Key customers
Cryo-Cell International Inc. - Segment focus
Cryoviva Biotech Pvt. Ltd. - Overview
Cryoviva Biotech Pvt. Ltd. - Product and service
Cryoviva Biotech Pvt. Ltd. - Key offerings
Cryoviva Biotech Pvt. Ltd. - Key customers
Cryoviva Biotech Pvt. Ltd. - Segment focus
FUJIFILM Holdings Corp. - Overview
FUJIFILM Holdings Corp. - Business segments
FUJIFILM Holdings Corp. - Key offerings
FUJIFILM Holdings Corp. - Key customers
FUJIFILM Holdings Corp. - Segment focus
Global Cord Blood Corp. - Overview
Global Cord Blood Corp. - Business segments
Global Cord Blood Corp. - Key offerings
Global Cord Blood Corp. - Key customers
Global Cord Blood Corp. - Segment focus
PerkinElmer Inc. - Overview
PerkinElmer Inc. - Business segments
PerkinElmer Inc. - Key offerings
PerkinElmer Inc. - Key customers
PerkinElmer Inc. - Segment focus
Plus Therapeutics Inc. - Overview
Plus Therapeutics Inc. - Business segments
Plus Therapeutics Inc. - Key offerings
Plus Therapeutics Inc. - Key customers
Plus Therapeutics Inc. - Segment focus
Currency conversion rates for US$
Research Methodology
Validation techniques employed for market sizing
Information sources
List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global stem cell banking market: Cordlife Group Ltd., CordVida, Covis Pharma BV, Cryo Stemcell, Cryo-Cell International Inc., Cryoviva Biotech Pvt. Ltd., FUJIFILM Holdings Corp., Global Cord Blood Corp., PerkinElmer Inc., and Plus Therapeutics Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing demand for personalized medicines.'

According to the report, one of the major drivers for this market is the increased federal investment in stem cell therapy.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.